Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
Rubric Capital Management LP reported a 8.06% stake in Ars Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Rubric Capital Management LP reported a 8.06% stake in Ars Pharmaceuticals, Inc., 8,000,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 8.06%
- Shares
- 8,000,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Rubric Capital Management LP | 8.06% | 8,000,000 |
| David Rosen | 8.06% | 8,000,000 |
Source
Related
- Ars Pharmaceuticals, Inc.
- Rubric Capital Management LP
- Ars Pharmaceuticals, Inc. shareholders
- Schedule 13G · Rubric Capital Management LP · Feb 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 14, 2026
- Form 4 · Karas Eric · Jun 12, 2026
- Form 4 · Fitzpatrick Alexander A · Jun 12, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026